Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Todd Anderman currently holds 87,568 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Todd Anderman has been a net seller of OCUL stock. They have purchased $0 and sold $137.4K worth of shares.
Todd Anderman's most recent insider trade was on Oct 8, 2025, when they sold 11,132 shares at $12.34 per share.
Todd Anderman serves as Executive at OCULAR THERAPEUTIX, INC (OCUL). They have executed 2 insider transactions totaling $137.4K over their tenure at the company.
Todd Anderman holds the position of Executive at OCULAR THERAPEUTIX, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Todd Anderman has shown a selling trading pattern, with $0 in total purchases and $137.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Todd Anderman was on Oct 8, 2025, when they sold $137.4K worth of OCUL shares. This transaction involved 11,132 shares at $12.34 per share.
Todd Anderman currently owns 87,568 shares of OCULAR THERAPEUTIX, INC (OCUL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Todd Anderman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Todd Anderman has 2 Form 4 filings on record as an insider at OCULAR THERAPEUTIX, INC.
Set alerts for Todd Anderman and 40,000+ other insiders.